Two examples of changes in assay methods involve creatinine and cystatin C. Creatinine measurement using the Jaffe method has been shown to exhibit non-creatinine chromogenic interference in samples from patients with diabetes [16,17]. The gene discussed is CST3; the disease is diabetes mellitus.